Przejdź do zawartości
Merck

19589

Sigma-Aldrich

L-2,4-Diaminobutyric acid monohydrochloride

≥98.0% (AT), ≥98.0% (TLC)

Synonim(y):

DAB

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych


About This Item

Wzór empiryczny (zapis Hilla):
C4H10N2O2 · HCl
Numer CAS:
Masa cząsteczkowa:
154.60
Beilstein:
6086583
Numer MDL:
Kod UNSPSC:
12352200
Identyfikator substancji w PubChem:

Próba

≥98.0% (AT)
≥98.0% (TLC)

Postać

powder or crystals

aktywność optyczna

[α]20/D +24±2°, c = 1.2% in 6 M HCl

metody

ligand binding assay: suitable

kolor

white to off-white

mp

≥220 °C (dec.) (lit.)

Zastosowanie

peptide synthesis

ciąg SMILES

Cl[H].NCC[C@H](N)C(O)=O

InChI

1S/C4H10N2O2.ClH/c5-2-1-3(6)4(7)8;/h3H,1-2,5-6H2,(H,7,8);1H/t3-;/m0./s1

Klucz InChI

BFPDKDOFOZVSLY-DFWYDOINSA-N

Działania biochem./fizjol.

L-2,4-Diaminobutyric acid (DAB) is a substrate of diaminobutyrate-pyruvate transaminase (EC 2.6.1.46), an enzyme involved in an alternative polyamine biosynthesis pathway in bacteria.
L-2,4-Diaminobutyric acid (DAB, DABA), a non-metabolized amino acid, is useful as a selective GABA uptake inhibitor which may have antitumour activity against hepatoma cells.
Ta strona może zawierać tekst przetłumaczony maszynowo.

Kod klasy składowania

11 - Combustible Solids

Klasa zagrożenia wodnego (WGK)

WGK 3

Środki ochrony indywidualnej

Eyeshields, Gloves, type N95 (US)


Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Ryo Inada et al.
World journal of gastroenterology, 21(7), 2159-2168 (2015-02-27)
To analyze the mismatch repair (MMR) status and the ARID1A expression as well as their clinicopathological significance in gastric adenocarcinomas. We examined the expressions of MMR proteins and ARID1A by immunohistochemistry in consecutive 489 primary gastric adenocarcinomas. The results were
Florence Coussy et al.
International journal of cancer, 145(7), 1902-1912 (2019-03-13)
Triple-negative breast cancer (TNBC) represents 10% of all breast cancers and is a very heterogeneous disease. Globally, women with TNBC have a poor prognosis, and the development of effective targeted therapies remains a real challenge. Patient-derived xenografts (PDX) are clinically
Mirko Manetti et al.
Journal of clinical medicine, 8(7) (2019-07-03)
Hemophilic arthropathy (HA) typically begins with proliferative synovitis that shares some similarities with inflammatory arthritides, in which the proinflammatory cytokine tumor necrosis factor (TNF)-α has a crucial pathogenetic role. Inappropriate release of TNF-α was shown to contribute to arthropathy development
Mei-Ling Chen et al.
Medicina (Kaunas, Lithuania), 55(7) (2019-07-10)
Prostate cancer (PCa) is a common malignancy in males and has a relatively slower progression than other cancers. Our goal was to evaluate the clinical role of SPARC (secreted protein acidic and cysteine rich, osteonectin), cwcv, and kazal-like domains' proteoglycan
Feng Liu et al.
Archives of gynecology and obstetrics, 300(3), 711-716 (2019-06-12)
To investigate the expression of annexin A2 (ANXA2) in ectopic and eutopic endometrium and serum of women with adenomyosis, and their relationships with adenomyosis-associated dysmenorrhea. The expression of ANXA2 was detected by immunohistochemical S-P method in ectopic and eutopic endometrium

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej